About Us
Through integration of digital twins and in silico dissolution, we are transforming the mindset around drug development. Combining advanced microscopic analysis with computational physics, our platform provides a full spectrum understanding of drug product properties and performance.
We work closely with leading innovators and generic developers to navigate development challenges and institutionalize knowledge libraries. Collaborating with regulatory bodies, we are paving the way for an advanced understanding of the role microstructures play in product quality, while also bridging the gap between industry and agencies.
Our solutions are powered by digiM I2S, our cloud-based software which integrates AI image processing, structural analytics, Generative AI, simulation, and data management.
Our History
digiM was founded in 2014 by Dr. Shawn Zhang. We champion the combined the power of experimental data and computational physics modeling. digiM is a recognized world leader in the science and engineering of microstructures. Adapting our past expertise in the geoscience and energy material sectors, we integrate best in class technologies for image processing, microstructure analysis, and simulation.
Digital Transformation Mission
Imago, the butterfly in our logo, represents our continuous journey to transform material science and drug development with digital twins and in silico prediction.
Transform Your Program with Microstructure Science
Get started with a drug product digital twin.
